Hey there, great course, right? Do you like this course?

All of the most interesting lessons further. In order to continue you just need to purchase it

Optimizing the treatment of Len Refractory Patients

Lesson is locked. Please Buy course to proceed.

Maximizing the benefits for 1st Relapse RRMM Patients: Case Presentation
Completed
CANDOR: Carfilzomib, Dexamethasone, & Daratumumab Versus Carfilzomib & Dexamethasone for Relapsed Multiple Myeloma